Skip to content
FrontierPicks

Dossier · PLMR · Dormant

PLMR · Palomar Holdings, Inc. · Stock research

Last analysed ·

Current thesis

Beat-and-raise did not hold: Q2 (2026-08-04) printed GWP $630.5M +27% YoY, adjusted EPS $2.36 and a third FY26 guidance raise to $270–280M, yet the 2026-08-14 close is $128.21 against a $145.29 52-week high with RSI(14) 29.8. Earnings keep compounding while the multiple de-rates with the P&C group; the $125 shelf decides pullback versus failed breakout.

Kill line

A weekly close below $125 turns the July breakout into a failed one and returns price to the pre-breakout range (post-Q1 base near $120); secondarily, a Q3 print (~2026-11-03, est.) with GWP growth under ~20% or an adjusted combined ratio above 85%.

Pick status

Open commitment catalyst 7d agoscored if the kill line above fires How this is scored →

Latest analysis and events for PLMR —

As of 16 August 2026, the latest FrontierPicks analysis for Palomar Holdings, Inc. (PLMR): Beat-and-raise did not hold: Q2 (2026-08-04) printed GWP $630.5M +27% YoY, adjusted EPS $2.36 and a third FY26 guidance raise to $270–280M, yet the 2026-08-14 close is $128.21 against a $145.29 52-week high with RSI(14) 29.8. Earnings keep compounding while the multiple de-rates with the P&C group; the $125 shelf decides pullback versus failed breakout.

Kill line: A weekly close below $125 turns the July breakout into a failed one and returns price to the pre-breakout range (post-Q1 base near $120); secondarily, a Q3 print (~2026-11-03, est.) with GWP growth under ~20% or an adjusted combined ratio above 85%.

Most recent dated event on file: — catalyst 7d ago.

Current Thesis

The 2026-08-03/04 print resolved the binary in favour of the fundamentals and the tape ignored it. Q2 2026 gross written premium was $630.5M, +27.0% YoY; adjusted net income $63.8M (+31.4%) on adjusted diluted EPS of $2.36; adjusted combined ratio 76.7%; annualized adjusted ROE ~26%. Management lifted full-year adjusted net income guidance to $270–280M — the third raise of 2026 — and declared the company's first-ever quarterly dividend at $0.45. Price went the other way: from a third-party close of $136.82 on 2026-08-06 to a reference close of $128.21 on 2026-08-14, 11.8% under the $145.29 52-week high, with RSI(14) at 29.8. The narrative leg on offer is a specialty-P&C underwriter whose earnings power is being revised up three times in a year while its multiple compresses alongside the property-casualty group. What is unresolved is whether the July breakout was real: the advance that carried it to new highs on the KBW/Piper/J.P. Morgan target cluster (2026-07-08 through 2026-07-20) has given back a large part of itself, and no new base has formed underneath.

Bullish and bearish views on Palomar Holdings, Inc.

The model's bull view on Palomar Holdings, Inc. (PLMR), in brief: Q2 2026 (released 2026-08-04): GWP $630.5M +27.0% YoY, net written premium $325.2M +41.5%, net earned premium $287.0M +59.5% — retention of premium is rising faster than gross production, which is where the earned-premium leverage comes from. The bear view: Premium growth decelerated hard: +42.4% YoY in Q1 2026 to $629.8M, +27.0% in Q2 to $630.5M. Both cases follow in full.

Bull Case

  • Q2 2026 (released 2026-08-04): GWP $630.5M +27.0% YoY, net written premium $325.2M +41.5%, net earned premium $287.0M +59.5% — retention of premium is rising faster than gross production, which is where the earned-premium leverage comes from.
  • Adjusted net income $63.8M, +31.4% YoY, adjusted diluted EPS $2.36 versus the $2.18 consensus recorded by Benzinga on 2026-08-04; company describes it as the 15th consecutive quarterly beat.
  • FY26 adjusted net income guidance raised to $270–280M from the $262–278M set with Q1 on 2026-05-06 — the third increase this year — with adjusted ROE guided above 20%.
  • the quarter carried effectively no event drag.
  • Capital return started: 368,719 shares repurchased for $41.0M in Q2 under the $200M authorization dated 2026-05-06 (runs to 2028-05-06), plus an initial $0.45 quarterly dividend declared 2026-07-30 (record 2026-08-19, payable 2026-09-02). A first dividend widens the eligible holder base to income mandates.
  • Sell-side has not marked down with price: KBW maintained Outperform and raised its target to $167 on 2026-08-11, a week after the print; stockanalysis.com's forecast page shows a consensus average target of $156.43 across seven analysts (range $100–$178), retrieved 2026-08-16.
  • Surety & Credit GWP was reported up 236% YoY as the Gray integration completed — line diversification away from the legacy earthquake concentration continues (Q2 2026 results coverage, 2026-08-04).

Bear Case

  • Premium growth decelerated hard: +42.4% YoY in Q1 2026 to $629.8M, +27.0% in Q2 to $630.5M. Sequentially the gross line is flat. A compounder story priced on 40%-handle growth is now running at 27%.
  • Underwriting margin keeps giving: loss ratio 34.5% in Q2 versus 25.7% a year earlier; GAAP combined ratio 83.3% versus 78.8%; adjusted combined 76.7% versus 73.1%. Q1 2026 showed the same direction (84.5% combined versus 73.1%). Mix shift into casualty and crop is doing it.
  • The GAAP line grows far slower than the adjusted line: net income $52.6M / $1.94 diluted EPS, +13.0% YoY, against +31.4% adjusted. The guidance framework is stated in adjusted terms only.
  • Price is not paying for the beat. Third-party quote data put the stock at $136.82 on 2026-08-06 with a market cap of $3.63B and a year-to-date gain of 1.53% — roughly flat on the year while adjusted earnings compound near 30%. By 2026-08-14 the reference close was $128.21.
  • The peak of the Atlantic hurricane season (climatological peak around 2026-09-10) sits directly ahead of a book with earthquake and wind exposure; the $8–12M full-year cat estimate assumes an ordinary season.
  • No company catalyst inside 30 days. After the 2026-09-02 dividend payment the next scheduled binary is the Q3 print, roughly 2026-11-03 (est.) — eleven weeks with nothing dated to re-rate against.

Setup & Price Structure

  • MEASURED: reference close $128.21 on 2026-08-14; 52-week high $145.29 (−11.8%); 52-week low $100.81; three-month return +15.7%; RSI(14) 29.8, the low end of its range.
  • The July advance ran from the post-Q1 base to new highs on a twelve-day target cluster — KBW $166 (2026-07-08), Piper Sandler upgrade to Overweight $165 (2026-07-15), J.P. Morgan $167 (2026-07-20) — and the 2026-07-26 reference close was $140.80. Most of that leg has been surrendered without a single dated negative company event.
  • $125 is the line that separates a pullback inside the uptrend from a failed breakout; below it the post-Q1 consolidation near $120 is the next structural reference, and $100.81 marks the 52-week floor. Price at $128.21 sits directly on top of that decision zone, and no reversal structure has formed yet.
  • Crowding observables, stated as observables: seven covering analysts averaging a $156.43 target well above spot with no post-print cuts in the reviewed record; a company buying its own stock ($41.0M in Q2); no insider transactions in the filings reviewed for this note; no earnings date inside 30 days. The positioning risk here is analyst targets that have not been re-marked to a de-rating tape, not a retail crowd.
  • MEASURED: Benzinga's 2026-08-04 headline recorded sales of $286.951M against a $619.420M estimate. INFERRED: $286.951M matches the reported net earned premium line ($287.0M), while $619.42M sits at the scale of a gross-written-premium consensus ($630.5M reported) — screen-level "revenue miss" propagated from two different lines, which is a plausible contributor to the initial reaction but is not a like-for-like comparison.

Catalyst Calendar (next 30 days)

  • 2026-09-02 — first dividend payment. Completes the income-mandate eligibility change begun with the 2026-07-30 declaration.
  • Through 2026-10-31, peak ~2026-09-10 — Atlantic hurricane season. The live variable against the $8–12M full-year catastrophe load; a landfall event in the wind/earthquake footprint is the one thing that can decouple this name from the P&C group inside the window.
  • ~2026-11-03 (est.) — Q3 2026 results, outside the 30-day window and the next scheduled test of the growth and combined-ratio trajectory.

Elapsed catalysts

  • 2026-08-19 — record date (and reported ex-date) for the first-ever $0.45 quarterly dividend. Dividend-adjusted daily bars — the series any level here is graded against — will reflect it from this date. (passed 7d ago)

What Would Change Our Mind

The structural question is whether the July breakout shelf holds. Price has already returned to it; losing it converts a strong-fundamental pullback into a failed breakout with an eleven-week catalyst vacuum behind it. A weekly close below $125 is the gradeable version of that break, with the deeper post-Q1 base near $120 as the next reference. On the fundamentals, a Q3 print (~2026-11-03, est.) with GWP growth decelerating below roughly 20% — the trend line from +42.4% to +27.0% extended — or an adjusted combined ratio above 85% would break the profitable-growth frame that the guidance raises rest on. A catastrophe quarter that pushes reported cat losses through the $8–12M full-year estimate would do the same by a different route. The opposite evidence: a weekly close back above $140 with the buyback still running at the Q2 pace would say the de-rating was group beta rather than a verdict on this book.

Correlation Notes

  • Trades as part of the specialty and E&S property-casualty complex (KNSL, RLI, SKWD, HCI, AXS). Third-party coverage on 2026-08-04–08-06 attributed the post-print weakness to sector caution rather than company results — the group's softening property-rate cycle is the visible driver, and PLMR has been moving with it despite beating.
  • Cat-exposed lines link it to reinsurance and cat-bond pricing; historically a large event repriced the reinsurance lines it buys, so a hurricane hit is both an earnings and a cost-of-capacity event.
  • Quote-page beta near 0.41 means little natural index-driven bid arrives on market rallies; the July move was analyst-flow driven and the August unwind has been equally flow-driven.
  • Crop and surety exposure add an agricultural-price and construction-cycle correlation that the pre-2024 earthquake-heavy book did not have; Surety & Credit GWP +236% YoY in Q2 2026 makes that a material rather than a rounding-error linkage.

Notes

  • Growth and margin are reported in adjusted terms; Q2 2026 GAAP net income grew 13.0% versus 31.4% adjusted, and all guidance is stated on the adjusted line.
  • Cat-exposed book (earthquake, wind) into Atlantic hurricane season Aug–Oct; company estimates $8–12M of full-year 2026 catastrophe losses.
  • $200M buyback authorized 2026-05-06 and running to 2028-05-06; $41.0M of it used in Q2 2026.
  • First-ever dividend initiated 2026-07-30 at $0.45/quarter; dividend-adjusted price series reflect it from the 2026-08-19 record/ex date.
  • Sector tag is specialty P&C — earthquake, casualty, crop, inland marine, surety — not managed care; an earlier mis-tag was corrected in July 2026.
  • Screeners compared Q2 net earned premium ($287.0M) to a gross-premium-scale consensus (~$619M), so headline 'revenue miss' data on this name is not like-for-like.

Related · shared themes

HUM

Humana Inc.

Margin-over-volume Medicare Advantage reset reclaimed its trend: the 2026-08-24 close of $386.61 is 2.0% above the prior session and back clear of the last 50-day value observed ($378.33, 2026-08-12), with RSI(14) at 64.6 from 52.5. Revision flow idle since Bernstein's 08-14 Buy/$425, and the 2027 number now has a venue — a 2026-12-10 investor update — past both the 09-08/10 conference window and the 11-06 print. The narrative is maturing.

MEDIUM

RXO

RXO, Inc.

Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to consensus; the ~2026-08-05 Q2 print (adj EBITDA guide $27–37M vs $6M Q1) is the binary the whole re-rate discounts.

MEDIUM

CNC

Centene Corporation

Margin-repair guide raise of 2026-07-28 stays fully priced: the 2026-08-24 close of $65.65 is 2.7% under the 2026-08-14 close of $67.47 and 4.5% below the $68.72 52-week high, with no analyst target moved since Argus on 2026-08-11. maturing; the next company-controlled datapoint is Q3, now calendared 2026-10-27.

LOW

HNGE

Hinge Health, Inc.

Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating insider selling mark a late, distribution-prone phase, with no company catalyst until the ~2026-08-04 Q2 print.

LOW